{
    "clinical_study": {
        "@rank": "97600", 
        "acronym": "SAYANA", 
        "arm_group": [
            {
                "arm_group_label": "prevention of pregnancy", 
                "description": "Non intervention"
            }, 
            {
                "arm_group_label": "management of endometriosis-associated pain", 
                "description": "Non intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "Post Marketing Surveillance To Observe Safety And Efficacy Of Sayana\u00ae Used For Contraception\n      And Management Of Endometriosis-Associated Pain"
        }, 
        "brief_title": "Post Marketing Surveillance Study For Sayana\u00ae", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Product Surveillance, Postmarketing", 
        "condition_browse": {
            "mesh_term": "Endometriosis"
        }, 
        "detailed_description": {
            "textblock": "Post Marketing Surveillance required by Korea MFDS regulation. Select among patients who\n      randomly visit the site who meet the inclusion/exclusion criteria."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Subjects or legally authorized representatives of pediatric subjects agree to provide\n        written informed consent form (ie, data privacy statement).\n\n        2.Women subjects who are initiating treatment with Sayana\u00ae for the first time as per the\n        local product document for usage\n\n        Exclusion Criteria:\n\n          -  Known or suspected pregnancy.\n\n          -  Undiagnosed vaginal bleeding.\n\n          -  Known or suspected malignancy of breast.\n\n          -  Active thrombophlebitis, or current or past history of thromboembolic disorders, or\n             cerebral vascular disease.\n\n          -  Significant liver disease.\n\n          -  Known hypersensitivity to medroxyprogesterone acetate or any of its other\n             ingredients.\n\n          -  Women who are before menarche or who are post-menopausal.\n\n          -  Treatment with any investigational agent or device within 30 days prior to the\n             enrollment visit."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Women subjects who are initiating treatment with Sayana\u00ae for the first time as per the\n        local product document for usage"
            }
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02104557", 
            "org_study_id": "A6791036"
        }, 
        "intervention": [
            {
                "arm_group_label": "prevention of pregnancy", 
                "description": "Non intervention", 
                "intervention_name": "Non intervention", 
                "intervention_type": "Other", 
                "other_name": "Non intervention"
            }, 
            {
                "arm_group_label": "management of endometriosis-associated pain", 
                "description": "Non intervention", 
                "intervention_name": "Non intervention", 
                "intervention_type": "Other", 
                "other_name": "Non intervention"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Sayana", 
            "Pregnancy", 
            "Contraception", 
            "Endometriosis-associated pain", 
            "PMS", 
            "Post Marketing Surveillance"
        ], 
        "lastchanged_date": "April 1, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6791036&StudyName=Post%20Marketing%20Surveillance%20Study%20For%20Sayana%AE"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Gunpo-si", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi-Do", 
                        "zip": "435-849"
                    }, 
                    "name": "Sanborn jeil Women's Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seongnam-si", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi-do", 
                        "zip": "463-811"
                    }, 
                    "name": "Baylor Ewha Obgyn Clinic"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "156-806"
                    }, 
                    "name": "Cheong Wha Wonen's Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "137-809"
                    }, 
                    "name": "Nana Clinic"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "135-932"
                    }, 
                    "name": "Roen Clinic"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "2", 
        "official_title": "Post Marketing Surveillance To Observe Safety And Efficacy Of Sayana\u00ae Used For Contraception And Management Of Endometriosis-Associated Pain", 
        "overall_contact": {
            "last_name": "Pfizer CT.gov Call Center", 
            "phone": "1-800-718-1021"
        }, 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Cumulative percent of patients who become pregnant over the 6 month observation period and rate of pregnancies per 100 person-years of follow-up", 
                "safety_issue": "No", 
                "time_frame": "6 month"
            }, 
            {
                "description": "The subject will be asked to indicate the subjective level of endometriosis pain looking back at the last 3 months and mark it with a single vertical mark on the 100mm horizontal visual analogue scale, where 0 mm represents absence of pain and 100mm indicates unbearable pain", 
                "measure": "The patient response to endometriosis pain treatment: endometriosis pain treatment effect will be measured by visual analogue scale scores recorded by the subjects at each visit.", 
                "safety_issue": "No", 
                "time_frame": "3 month"
            }, 
            {
                "measure": "Incidence of adverse events categorized according to physical organ and disease/symptom.", 
                "safety_issue": "Yes", 
                "time_frame": "6 month"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02104557"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}